182 related articles for article (PubMed ID: 35981776)
1. Heterogeneous impact of the COVID-19 pandemic on lung, colorectal and breast cancer incidence in Hungary: results from time series and panel data models.
Elek P; Csanádi M; Fadgyas-Freyler P; Gervai N; Oross-Bécsi R; Szécsényi-Nagy B; Tatár M; Váradi B; Zemplényi A
BMJ Open; 2022 Aug; 12(8):e061941. PubMed ID: 35981776
[TBL] [Abstract][Full Text] [Related]
2. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
[TBL] [Abstract][Full Text] [Related]
3. Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healthcare pathway to diagnosis during 2020 in Wales, UK, using a national cancer clinical record system.
Greene G; Griffiths R; Han J; Akbari A; Jones M; Lyons J; Lyons RA; Rolles M; Torabi F; Warlow J; Morris ERA; Lawler M; Huws DW
Br J Cancer; 2022 Aug; 127(3):558-568. PubMed ID: 35501391
[TBL] [Abstract][Full Text] [Related]
4. Impact of COVID-19 control on lung, breast, and colorectal pathological cancer diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and Northern Ireland.
Mitchell H; Mclean J; Gavin AT; Visser O; Millar E; Luff T; Bennett D
BMC Cancer; 2023 Jul; 23(1):700. PubMed ID: 37495980
[TBL] [Abstract][Full Text] [Related]
5. Statewide Examination of Access to Cancer Surgery During the COVID-19 Pandemic.
Adams EJ; Feinglass JM; Hae-Soo Joung R; Odell DD
J Surg Res; 2023 Jun; 286():8-15. PubMed ID: 36724572
[TBL] [Abstract][Full Text] [Related]
6. Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race.
Berrian J; Liu Y; Ezenwajiaku N; Moreno-Aspitia A; Holton SJ; Toriola AT; Colditz GA; Housten AJ; Hall L; Fiala MA; Ademuyiwa FO
Cancer Med; 2023 Mar; 12(6):7381-7388. PubMed ID: 36404491
[TBL] [Abstract][Full Text] [Related]
7. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
Chen RC; Haynes K; Du S; Barron J; Katz AJ
JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
[TBL] [Abstract][Full Text] [Related]
8. Decreasing incidence and mortality of lung cancer in Hungary between 2011 and 2021 revealed by robust estimates reconciling multiple data sources.
Gálffy G; Szabó GT; Tamási L; Müller V; Moldvay J; Sárosi V; Kerpel-Fronius A; Kardos T; Csada E; Pápai-Székely Z; Szász Z; Király Z; Hódi G; Kovács Z; Balogh É; Kovács KA; Darida M; Buga V; Rokszin G; Abonyi-Tóth Z; Kiss Z; Vokó Z; Bogos K
Pathol Oncol Res; 2024; 30():1611754. PubMed ID: 38887697
[TBL] [Abstract][Full Text] [Related]
9. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands.
Dinmohamed AG; Cellamare M; Visser O; de Munck L; Elferink MAG; Westenend PJ; Wesseling J; Broeders MJM; Kuipers EJ; Merkx MAW; Nagtegaal ID; Siesling S
J Hematol Oncol; 2020 Nov; 13(1):147. PubMed ID: 33148289
[TBL] [Abstract][Full Text] [Related]
10. New Cancer Diagnoses Before and During the COVID-19 Pandemic.
Decker KM; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Pitz M; Singh H; Thiessen M; Lambert P
JAMA Netw Open; 2023 Sep; 6(9):e2332363. PubMed ID: 37669049
[TBL] [Abstract][Full Text] [Related]
11. Impact of coronavirus disease 2019 on the number of newly diagnosed cancer patients and examinations and surgeries performed for cancer in Japan: a nationwide study.
Terashima T; Konishi H; Sato Y; Igarashi M; Yanagibashi T; Konno R; Saya H; Doki Y; Kakizoe T
BMC Cancer; 2022 Dec; 22(1):1303. PubMed ID: 36514005
[TBL] [Abstract][Full Text] [Related]
12. Delay and Disparity in Observed vs Predicted Incidence Rate of Screenable Cancer During the COVID-19 Pandemic.
Romatoski KS; Chung SH; Kenzik K; Rasic G; Ng SC; Tseng JF; Sachs TE
J Am Coll Surg; 2023 Sep; 237(3):420-430. PubMed ID: 37227063
[TBL] [Abstract][Full Text] [Related]
13. A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
Joung RH; Nelson H; Mullett TW; Kurtzman SH; Shafir S; Harris JB; Yao KA; Brajcich BC; Bilimoria KY; Cance WG
Cancer; 2022 Jun; 128(11):2119-2125. PubMed ID: 35307815
[TBL] [Abstract][Full Text] [Related]
14. Socioeconomic factors and colorectal cancer incidence, stage and quality of care in Denmark during the COVID-19 pandemic.
Weinberger Rosen A; Jensen H; Olesen TB; Møller H; Jensen JW; Gögenur I
Cancer Epidemiol; 2023 Oct; 86():102447. PubMed ID: 37633057
[TBL] [Abstract][Full Text] [Related]
15. Cancer incidence during the COVID-19 pandemic by region of residence in Manitoba, Canada: A cancer registry-based interrupted time series study.
Decker KM; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Singh H; Thiessen M; Pitz M; Musto G; Galloway K; Lambert P
Cancer Med; 2023 Dec; 12(23):21465-21479. PubMed ID: 37974380
[TBL] [Abstract][Full Text] [Related]
16. The Early Impact of the COVID-19 Pandemic on Lung, Colorectal, and Breast Cancer Screening and Treatment at a Tertiary Cancer Center.
Lou J; Kooragayala K; Williams JP; Sandilos G; Butchy MV; Yoon-Flannery K; Kwiatt M; Hong YK; Shersher DD; Burg JM
Am J Clin Oncol; 2022 Sep; 45(9):381-390. PubMed ID: 35983965
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the impact of COVID-19 on cancer declarations in Quebec, Canada.
Ramanakumar AV; Annie B; Frederic L; Christine B; Cathy R; Jean L
Cancer Med; 2023 Mar; 12(5):6260-6269. PubMed ID: 36385491
[TBL] [Abstract][Full Text] [Related]
18. [Participation indicators of colorectal screenings in Hungary between 2008-2021].
Kívés Z; Bódis J; Hunyady B; Pónusz-Kovács D; Elmer D; Kajos FL; Csákvári T; Vajda R; Boncz I
Magy Onkol; 2022 Oct; 66(3):209-217. PubMed ID: 36200501
[TBL] [Abstract][Full Text] [Related]
19. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
[TBL] [Abstract][Full Text] [Related]
20. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
